Go to
JCI Insight
Citations to this article
Norman R. Augustine
Published December 1, 2014
Citation Information: J Clin Invest. 2014;124(12):5087-5089. https://doi.org/10.1172/JCI79617.
Citation Information: J Clin Invest. 2014;124(12):5087-5089. https://doi.org/10.1172/JCI79617.
Abstract
As the US addresses its budget dilemma, the easiest items to cut are those with the longest-term payoff. Research stands out among this group. Biomedical research has already been markedly reduced, and further reductions appear to be in store. As a frequent witness in Congressional hearings on such matters, here I discuss the challenge of assessing the value of investments in biomedical research.
Authors
Norman R. Augustine
Citation information
Citations to this article (1)
| Title and authors | Publication | Year |
|---|---|---|
|
Citation Impact of NHLBI R01 Grants Funded Through the American Recovery and Reinvestment Act as Compared to R01 Grants Funded Through a Standard Payline
NS Danthi, CO Wu, DM DiMichele, WK Hoots, MS Lauer |
Circulation research | 2015 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)